Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
5.81
-0.16 (-2.68%)
At close: Mar 28, 2025, 4:00 PM
5.76
-0.05 (-0.86%)
After-hours: Mar 28, 2025, 7:59 PM EDT
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $2.34 billion as of March 28, 2025. Its market cap has decreased by -9.46% in one year.
Market Cap
2.34B
Enterprise Value
1.85B
1-Year Change
-9.46%
Ranking
Category
Stock Price
$5.81
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $2.34B, a decrease of -53.95%. That is a compound annual growth rate of -17.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 2.34B | -12.34% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.66B |
| UnitedHealth Group | 471.76B |
| Johnson & Johnson | 394.47B |
| AbbVie | 362.98B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 226.85B |
| Merck & Co. | 225.37B |
| AstraZeneca | 225.00B |